Steris GmbH joins GEA Group
Steris GmbH, a Cologne (Germany) based manufacturer of freeze-drying units for the pharmaceutical and biotech industries, and subsidiary of US-based Steris Corporation, has become a member of the GEA Group's P-Division (Process Engineering Division), following its acquisition by GEA. It will now be known as GEA Lyophil.
The P-Division, one of eight divisions of the GEA Group, specialises in industrial drying, with spray and fluid bed processing as its core technologies. NPS is a specialist in the design and supply of equipment for the pharmaceutical industry. GEA will specifically deploy Steris as its worldwide technology centre for its lyophilisers for the pharmaceutical and biotechnology industries. Niro Inc, GEA's US company, will represent Steris' lyophiliser range in North America. "This acquisition is another valuable addition to our product portfolio for the biotechnology and pharmaceutical sectors," said Peter Schenk, GEA's executive board member. "Over the next few years, the demand for lyophilisers will be driven by the growth in pharmaceutical products produced via the biotech route."